期刊文献+

甲状腺乳头状癌CD44v6、VEGF-C的表达及临床意义

Expressions and Significance of CD44v6 and VEGF-C in Patients with Papillary Thyroid Carcinoma
下载PDF
导出
摘要 目的探讨甲状腺乳头状癌(FTC)中CD44v6和VEGF-C的表达及意义。方法应用免疫组织化学SP法检测78例甲状腺乳头状癌和18例甲状腺良性肿瘤中CD44v6和VEGF-C蛋白的表达,并进行比较。结果甲状腺乳头状癌组织中CD44v6和VEGF-C的阳性表达明显高于良性病变(P<0.05);CD44v6和VEGF-C的表达与甲状腺乳头状癌浸润程度及淋巴结转移有相关性(P<0.05);二者在甲状腺乳头状癌组织中表达呈正相关(P<0.05)。结论CD44v6和VEGF-C可能作为甲状腺乳头状癌的肿瘤标志物之一;CD44v6和VEGF-C表达与甲状腺乳头状癌浸润程度、淋巴结转移相关,二者联合检测对判断甲状腺乳头状癌侵袭与转移具有一定意义。 Objective To study the significance of CD44v6 and VEGF- C expressions in patients with papillary thyroid carcinoma(PTC). Methods Immunohistochemical SP method was used to detect the expressions of CD44v6 and VEGF - C in 72 cases with FIX2 and 18 cases with benign thyroid lesions; Using the mathod of statistics to compare clinical characteristics of PTC. Results The expression rate of CD44v6 and VEGF - C in PTC was significantly higher than that in benign thyroid lesions. There were correlation in the expression of CD44v6 and VEGF- C between the degree of infiltration and lymph node metastasis in PTC;There was signifi- candy positive correlation between the expression of CD44v6 and VEGF- C in PTC and were synergistic in action with one another. No correlation was found between age, sex and PTC. Conclusion CD44v6 and VEGF - C can be used as one of the markers of papillary thyroid carcinoma. The expression of CD44v6 and VEGF- C are correlated with the degree of infiltration and lymph node metastasis in PTC, which may be a significant parameters for determining invasiveness and metastasis of PTC.
出处 《宁夏医学院学报》 2008年第3期304-306,F0003,共4页 Journal of Ningxia Medical College
关键词 甲状腺肿瘤 CDddv6 VEGF—C 免疫组化 thyroid neoplasm CD44v6 VEGF-C immunohistochemistry
  • 相关文献

参考文献11

  • 1Kawano T, Nakamura Y, Yanoma S, et al. Expression of Ecadherin and CD44S and CD44V6 and its association with prognosis in head and neck cancer[J].Auris Nasus Larynx,2004,31 (1) :35.
  • 2Koyama Y, Kaneko K, Akazawa K, et al.Vascular endothehal growth factor C and vascular endothelial growth factor D messenger RNA expression in breast cancer: association with lymph node metastasis[ J]. Clin Breast Cancer,2003,4(5) : 354 - 360.
  • 3Akslen LA, Varhaug JE, Robinson L, et al. Oncoproteins and tumor progression in papillay thyroid carcinoma[J]. Cancer, 1995,76:1643.
  • 4Chhieng DC, Ross JS, Mckenna BJ, et al. CD44 immunostaining of thyroid fine - needle aspirates differentiates thyroid papillary carcinoma from other lesions with nuclear groves and inclusions[J]. Cancer, 1997,81(3) : 157.
  • 5翁文余,周小娜,刘金龙,王振杰.直肠癌CD44V6和VEGF表达的临床意义[J].实用癌症杂志,2006,21(1):26-29. 被引量:2
  • 6王旭东,邱志强,孙保存.CD44v6基因在甲状腺乳头状癌的表达及其临床意义[J].天津医科大学学报,2000,6(4):425-428. 被引量:2
  • 7Fellmer PT, Sato K, Tanaka R, et al. Vascular endothelial growth factor- C gene expression in papilary and follicular thyroid carinomas[ J]. Surgery, 1999,126(6) : 1056 - 1062.
  • 8张宏波,魏启幼.血管内皮生长因子-C及其受体Flt-4在甲状腺乳头状癌中的表达[J].中国医师杂志,2005,7(11):1465-1467. 被引量:3
  • 9Kitadai Y, Amioka T, Haruma K, et al. Clinicopathological signi - ficance of vascular endothelial growth factor(VEGF) - C in humae- sophageal squamous cell carcinomas[J]. Int J Cancer,2001,93(5) :662 - 666.
  • 10Nathanson SD. Insights into the mechanisms of lymph node metastasis[J]. Cancer,2003,98(2) :413 - 423.

二级参考文献35

  • 1刘荣.肿瘤浸润和转移过程中DCC、CD44的作用[J].中国肿瘤临床,1996,23(11):818-821. 被引量:6
  • 2Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice [J]. Science, 1997, 276: 1423-1425.
  • 3Fujimoto J, Toyoki H, Sato E, et al. Clinical implication of expression of vascular endothelial growth factor-C in metastatic lymph nodes of uterine cervical cancers [J]. Br J Cancer, 2004, 91(3):466-469.
  • 4Ishikawa M, Kitayama J, Kazama S, et al. expression of vascular endothelial growth factor(VEGF)-C in preoperative biopsy specimens and metastatic foci of regional lymph nodes in submucosal gastric carcinoma[J]. World J Surg Oncol, 2005, 3(1):2.
  • 5Mandriota SJ, Jussila L, Jeitsch M, et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis [J]. EMBO J, 2001, 20(4): 672-682.
  • 6Ristimaki A, Narko K, Enholm B, et al. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C [J]. J Biol Chem, 1998, 273(14): 8413-8418.
  • 7Fellmer PT, Sato K, Tanaka R, et al. Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas [J]. Surgery, 1999, 126(6): 1056-1061.
  • 8Skobe M, Hawighost T, Jockson DG, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis [J]. Nat Med, 2001, 7(2): 192-198.
  • 9Weidner N, Semple JP, Welliam WR et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma [J]. N Engl J Med, 1991, 324:1-8.
  • 10Kukk E, Lymboussaki A, Taria S, et al. VEGF-C receptor binding and pattern of expression with VEGF-3 suggests a role in lymphatic vascular development [J]. Development, 1996, 122: 3829-3837.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部